ask="25.80"
ask_size="200"
average_daily_volume="640174"
bid="25.10"
bid_size="600"
book_value="5.75"
change="+1.60"
change_from_200_day_moving_average="10.22"
change_from_50_day_moving_average="10.94"
change_from_52_week_high="-0.60"
change_From_52_week_low="16.26"
change_in_percent="+5.95%"
close="28.50"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.25"
ebitda="-70.16M"
eps_estimate_current_year="-2.39"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-2.79"
ex_dividend_date="N/A"
float_shares="23150000"
high="29.10"
high_52_weeks="29.10"
last_trade_date="2/21/2017"
last_trade_price="28.50"
last_trade_size="18514"
last_trade_time="4:00pm"
low="27.25"
low_52_weeks="12.24"
market_capitalization="1.06B"
moving_average_200_day="18.28"
moving_average_50_day="17.56"
name="Global Blood Therapeutics
Inc."
notes="N/A"
one_year_target_price="50.83"
open="27.85"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+55.87%"
percent_change_from_50_day_moving_average="+62.28%"
percent_change_from_52_week_high="-2.06%"
percent_change_from_52_week_low="+132.84%"
previous_close="26.90"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.68"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="37316000"
short_ratio="9.70"
stock_exchange="NMS"
symbol="GBT"
volume="1878808"
weeks_range_52="12.24 - 29.10"
